Stratification – Page 18 – Communicable Diseases Research

Epigenome-wide association study of COVID-19 severity with respiratory failure

Research article

Published on 2021-04-162022-10-05
Journal: EBioMedicine [Category] 바이오마커, 유전자 메커니즘,

Prevalence and factors associated with covid-19 vaccine hesitancy in Maranhão, Brazil

Original Article

Published on 2021-04-152022-10-29
Journal: Revista de Saúde Pública [Category] COVID-19, MERS, SARS,

[키워드] 95%CI adopted Analysis association Brazil calculated chi-square test clinical factor Clustering conducted Conhecimentos, Atitudes e Prática em Saúde Coronavirus Infections, prevention & control cross-sectional demographic characteristics Descriptive analysis estimate Factor female Final fixed frequencies group health condition health knowledge, attitudes, practice Health Surveys Hierarchical identify independent variable individual Infecções por Coronavirus, prevenção & controle Inquéritos Epidemiológicos Intention no statistical difference Older outcome participant Pearson Prevalence random Recusa de Vacinação psicologia reported symptom SARS-CoV-2 selected statistically Stratification systematic analysis the vaccine vaccination Vaccination Refusal, psychology Vaccine hesitancy variable was performed was selected
[DOI] 10.11606/s1518-8787.2021055003417 PMC 바로가기 [Article Type] Original Article

Human immunodeficiency virus and mortality from coronavirus disease 2019: A systematic review and meta-analysis

Review Article

Published on 2021-04-152022-10-28
Journal: Southern African Journal of HIV Medicine [Category] COVID-19,

[키워드] acute respiratory syndrome age AIDS Analysis Antiretroviral therapy ART article association CD4 cell Co-infection Comprehensive confidence interval coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient database described Europe evaluated future risk HIV Human Human immunodeficiency virus Immune status immunodeficiency virus indicated Interaction Meta-analysis Mortality objective observational studies Person PLWH PMC random-effect receive Result retrieved review risk factor risk of death SARS-CoV-2 SARS-CoV-2 vaccine scale searched statistically significant Stratification subgroup analysis systematic review the United State was performed were assessed
[DOI] 10.4102/sajhivmed.v22i1.1220 PMC 바로가기 [Article Type] Review Article

Risk stratification scores for hospitalization duration and disease progression in moderate and severe patients with COVID-19

COVID-19 중등도 및 중증 환자의 입원 기간 및 질병 진행에 대한 위험 계층 점수

Observational Study

Published on 2021-04-142022-09-01
Journal: BMC Pulmonary Medicine [Category] Fulltext, MERS, 임상, 진단,

[키워드] albumin assist C-reactive protein calibration clinical decision Clinical symptoms coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 outbreak COVID-19 patient creatinine Critical decision discrimination disease Disease progression evaluated Factor healthcare Healthcare provider healthcare providers high risk high risk patients hospital Hospitalization identifying Lactate lactate dehydrogenase Length of hospital stay less logistic regression model lymphocyte maximum body temperature median moderate neutrophil Neutrophil-to-lymphocyte ratio outbreak outcome outcomes Patient patients with moderate performed Platelet Platelet count poor prognosis predict Prognosis prognosis of patients prothrombin Prothrombin time recruited respiratory respiratory diseases Result retrospective cohort study risk Risk category risk score risk stratification Risk stratification score score severe COVID-19 Severe patient severe patients Stratification stratified supplementary material Support was used with COVID-19
[DOI] 10.1186/s12890-021-01487-6 PMC 바로가기 [Article Type] Observational Study

Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial

경증 또는 중등도의 COVID-19 폐렴으로 입원한 환자를 위한 염증 신호 억제제(MATIS)의 다군 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2021-04-122022-09-10
Journal: Trials [Category] 임상,

[키워드] 24 hours accounted Administered age agreement All participants Allergic reactions approved baseline blind blinded Blinding block Breastfeeding Caregivers cell proliferation childbearing potential clinical clinical outcomes clinically suspected college comparator completion Compliance Concomitant medication Contraception Controlled trial coronavirus COVID-19 COVID-19 disease COVID-19 pneumonia CPAP CRP Data monitoring committee Day death defined Desaturation determine diagnosed disease disease severity dissemination dose drug ECMO effective Efficacy element English enrolment exclusion experimental arm experimental intervention facemask FOS fostamatinib generate GRADE grade 3 Graft graft-versus-host-disease hepatic dysfunction hospital Hospital admission Hospital stay hospitalisation hospitalised patient Hospitalised patients Immune thrombocytopenia Imperial College Healthcare NHS Trust incidence information Informed consent inhibitor Inpatient Inpatients Intervention invasive Invasive mechanical ventilation invasive ventilation investigational agent investigator JAK1 JAK2 janus kinase Kinase inhibitor kinases Laboratory male participants MATIS Mild minimum moderate Moderate COVID-19 moderate to severe Modification multi-arm myelofibrosis nasal oxygen NHS Non-invasive non-invasive ventilation number objective Obstructive obstructive sleep apnoea opinion Ordinal Scale outcome oxygen Pairwise comparison pandemic parallel-group participant Patient Pneumonia polycythaemia vera principal investigator product progression promise proportion protocol random randomisation randomised randomised controlled trial receiving recruit recruited reduce reduce mortality reducing renal impairment renal replacement therapy replacement therapy required Requirement ruxolitinib Sample size sample size calculation Sample size calculations SARS-CoV2 infection scale Secondary objectives selective sequence severe allergic reaction Severe COVID-19 pneumonia severity severity of COVID-19 sexual intercourse signal sleep apnoea Sperm sperm donation spleen Splenomegaly Stage stage 2 Standard Standard of care statistical analysis status Stratification study drug Study protocol supplementary material Symptom systemic inflammation the WHO therapy thrombocytopenia translation Treatment Trial Trial registration Trust tyrosine tyrosine kinase inhibitor Venous Thromboembolism verbal website WHO with COVID-19
[DOI] 10.1186/s13063-021-05190-z PMC 바로가기 [Article Type] Letter

Supporting Parents & Kids Through Lockdown Experiences (SPARKLE) : A digital parenting support app implemented in an ongoing general population cohort study during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial

Lockdown Experiences(SPARKLE)를 통해 부모와 자녀 지원 : COVID-19 전염병 동안 진행 중인 일반 인구 집단 연구에서 구현된 디지털 육아 지원 앱: 무작위 통제 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2021-04-102022-09-10
Journal: Trials [Category] MERS, 임상,

[키워드] 1:1 adverse events Analysis automatically baseline baseline characteristics blind blinded Blinding changes in Child behaviour problems children clinical Cohort cohort study collected Community comparator Complete Controlled trial COVID-19 difficulty Digital health dissemination Effect Efficacy eight element eligible enrolled exacerbated examined experience Exploratory analyses facilitated Families FAU General population Graphics help implementation individual information Intervention lockdown longitudinal cohort study measure mental health moderate number objective on children outcome outcomes pandemic parallel group parent Parenting parents participant platform Pragmatic Primary outcome problem protocol provided public health Public health intervention Qualtrics randomisation randomised randomised controlled trial receive recruited reduce Registered reported Research resources Sample size selected senior statistician Space Standard Stratification strength Stress Study protocol supplementary material Support Supporting text treatment arm Trial Two-arm Usage was selected website
[DOI] 10.1186/s13063-021-05226-4 PMC 바로가기 [Article Type] Letter

Whole genome variation in 27 Mexican indigenous populations, demographic and biomedical insights

27 멕시코 토착 인구의 전체 게놈 변이, 인구 통계 및 생물 의학 통찰력

Clinical Trial

Published on 2021-04-082022-09-10
Journal: PLoS ONE [Category] MERS, SARS, 변종, 유전자 메커니즘, 임상, 치료기술,

[키워드] ACE2 allele frequency Analysis average block Coverage dataset demonstrated diabetes drug response effective enhancer Genetic Genome genome-wide analysis genomic genomic data genotypes group groups Haplotype Health health problems helping immune impair implementation indels individuals insulin insulin resistance involved mapped mechanisms Mexican Mexicans missense variant Native nuclear nuclear receptor nucleotide obesity pathway Personalized medicine phylogenetic analyses Phylogenetic analysis population genomics population level populations Positive selection PPARG prevalent problem promoter receptor reduce responsible SARS CoV SARS CoV-2 Sequencing single nucleotide variants Stratification variant variants Variation virus whole genome Whole genome sequencing
[DOI] 10.1371/journal.pone.0249773 PMC 바로가기 [Article Type] Clinical Trial

Variables associated with COVID-19 severity: an observational study of non-paediatric confirmed cases from the general population of the Basque Country, Spain

Observational Study

Published on 2021-04-012022-10-04
Journal: BMJ Open [Category] 임상,

[키워드] Admission affected age ageing effect Alter association associations Blood Care category Chemical chronic drug classification clinical variable confirmed case COVID-19 COVID-19 pandemic death drugs Factor General population Health Health status healthcare hospital inclusion criteria individual interfere methodology MOST nervous system organ outcome outcomes Patient positive PCR primary care Psychosis public health Public health intervention Regression Research research methods retrospective serology test severity Sex Sociodemographic Spain statistically significant statistics & Stratification suggested tree understanding variable were excluded with COVID-19
[DOI] 10.1136/bmjopen-2021-049066 PMC 바로가기 [Article Type] Observational Study

Socioeconomic Inequalities and Ethnicity Are Associated with a Positive COVID-19 Test among Cancer Patients in the UK Biobank Cohort

Article

Published on 2021-03-252022-10-31
Journal: Cancers [Category] COVID-19,

[키워드] 95%CI added Cancer cancer patient Cancer patients case-control study Cohort conducted Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 disease COVID-19 incidence COVID-19 infection COVID-19 test COVID-19 transmission diagnosed Epidemiology Ethnicity Evidence finding First wave FIVE group Haematological cancer higher risk highlight identify improvement increased risk independent risk factor index inequality Infection information knowledge less malignancy obesity Other outcome pandemic Pandemics participant positive risk risk factor Risk factors severity simple smoking socio-demographic Socioeconomic factor Stratification Test tested Treatment UK biobank vaccination
[DOI] 10.3390/cancers13071514 PMC 바로가기 [Article Type] Article

Risk stratification by long non‐coding RNAs profiling in COVID‐19 patients

COVID-19 환자의 긴 비코딩 RNA 프로파일링에 의한 위험 계층화

Original Article

Published on 2021-03-232022-09-10
Journal: Journal of Cellular and Molecular Medicine [Category] 바이오마커,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Algorithm Analysis caused coronavirus coronavirus disease Coronavirus disease 2019 COVID‐19 COVID‐19 patient COVID‐19 disease enrolled Frame function functions global pandemic Health healthy control healthy controls heterogeneous immune individuals information lack lncRNA Long mononuclear cell mononuclear cells nucleotide nucleotides Open reading frame operator Patient Peripheral blood Peripheral blood mononuclear cells pulmonary injury reported respiratory risk RNA RNA sequencing RNA‐seq SARS‐CoV‐2 SARS‐CoV‐2 infection severe acute respiratory syndrome Coronavirus Stratification subclass subtype Transcriptome valuable resource
[DOI] 10.1111/jcmm.16444 PMC 바로가기 [Article Type] Original Article